Data Analytics for cell and gene therapy by Dr. Ruchi Dass, @drruchibhatt

Cell and gene therapies are becoming more and more popular because of encouraging clinical results worldwide. Major pharma manufacturing companies have invested in the concept’s commercialization worldwide. Recently, we read about Takeda’s license for commercialization of Aloficel (developed by TiGenix), Celgene’s acquisition of Juno Therapeutics or Gilead’s acquisition of Kite Pharma. As this sector grows … Data Analytics for cell and gene therapy by Dr. Ruchi Dass, @drruchibhatt Read More »